| Date Checked | 2026-02-19 22:13:33 |
|---|---|
| Graham Number | (PB)20.78 vs (PE)31.52 |
| Over / Under Value Percentage | 104.67% vs 52.96% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | EXEL |
| AssetType | Common Stock |
| Name | Exelixis Inc |
| Description | Exelixis, Inc. is a prominent biotechnology firm based in Alameda, California, focused on the discovery and commercialization of innovative oncology therapies. Boasting a robust portfolio of approved drugs alongside a promising pipeline, Exelixis is strategically positioned to tackle substantial unmet needs in cancer treatment. The company's dedication to enhancing patient outcomes through cutting-edge research and development underpins its role as a significant contributor to the biopharmaceutical landscape. By relentlessly pursuing transformative cancer solutions, Exelixis aims to deliver meaningful value to both patients and investors. |
| CIK | 939767 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, UNITED STATES, 94502 |
| OfficialSite | https://www.exelixis.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 11885292000 |
| EBITDA | 850002000 |
| PERatio | 18.55 |
| PEGRatio | 2.268 |
| BookValue | 8.06 |
| DividendPerShare | None |
| EPS | 2.38 |
| RevenuePerShareTTM | 8.29 |
| ProfitMargin | 0.296 |
| OperatingMarginTTM | 0.429 |
| ReturnOnAssetsTTM | 0.177 |
| ReturnOnEquityTTM | 0.306 |
| RevenueTTM | 2288218000 |
| GrossProfitTTM | 2211037000 |
| DilutedEPSTTM | 2.38 |
| QuarterlyEarningsGrowthYOY | 0.725 |
| QuarterlyRevenueGrowthYOY | 0.108 |
| AnalystTargetPrice | 45.5 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 9 |
| AnalystRatingHold | 9 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 18.55 |
| ForwardPE | 15.97 |
| PriceToSalesRatioTTM | 5.19 |
| PriceToBookRatio | 5.73 |
| EVToRevenue | 5.06 |
| EVToEBITDA | 13.61 |
| Beta | 0.399 |
| 52WeekHigh | 49.62 |
| 52WeekLow | 31.9 |
| 50DayMovingAverage | 42.52 |
| 200DayMovingAverage | 40.48 |
| SharesOutstanding | 268112000 |
| SharesFloat | 232016000 |
| PercentInsiders | 2.205 |
| PercentInstitutions | 96.159 |
| ExDividendDate | None |
| dateChecked | 2026-02-19 22:13:33 |
| fresh | 1 |